Everyone’s voice matters in uplifting, encouraging and creating a conducive environment for a longer and healthier life. Each of us plays a vital role and need to work together to best help our patients with established NCDs and those at high risk of developing this type of diseases. We need to create guidelines and standards drawn from best scientific evidence for NCD prevention and treatment which are appropriate to the needs of our region.

    Welcome Message

    The Organizing Committee of The Second Non-communicable Diseases (NCD) Congress in the UAE is honored to invite you to attend this educational event which will take place on 7th & 8th January 2021 in Dubai, United Arab Emirates.

    The congress is under the patronage of His Highness Sheikh Hamdan Bin Rashid Al Maktoum, Deputy Ruler of Dubai, UAE Minister of Finance and President of the Dubai Health Authority. The Congress is organized by Sheikh Hamdan Bin Rashid Al Maktoum Award for Medical Sciences and is supported by different institutions and organizations including, Emirates Medical Association, American Heart Association, Ministry of Health & Prevention, Dubai Health Authority, Department of Health Abu Dhabi, Dubai Healthcare City Authority, Emirates Cardiac Society, Emirates Diabetes Society, Emirates Oncology Society, Emirates Allergy and Respiratory Society and Regional NCD Alliance.

    According to World Health Organization (WHO) 2018 report, NCDs (non-communicable diseases), also known as chronic diseases, which include cardiovascular disease, diabetes, cancer, and chronic respiratory disease, cause 71% of all deaths globally. These conditions share common risk factors including tobacco use, physical inactivity, alcohol consumption and unhealthy diets and also share common solutions, which provide a mutual platform for collaboration and joint advocacy.

    In United Arab Emirates, NCDs are estimated to account for 77% of all deaths. Due to this alarming data, the leadership of the Emirates has put the NCD at the top of its strategic plan to reduce local mortality cases. In fact, UAE Vision 2021 National Agenda aims to build a world-class health system in the country, and provide universal health coverage to protect the UAE society from non-communicable diseases.

    The role of all concerned associations, civil society and academia to support this vision is also of utmost importance. In 2014, the First NCD Congress in the UAE, organized by the Sheikh Hamdan Bin Rashid Al Maktoum Award for Medical Sciences, received an overwhelming response from the healthcare sector. Following its success, we are preparing the Second NCD Congress.

    We are looking forward to your support and involvement and we assure you that your participation in this congress will be a rewarding one.

    Sincerely,
    Congress Management Committee

    Sponsors

    Supported By

    In Collaboration with

    Endorsed by

    Committee and Faculty

    Dr. Omniyat Mohammad Al Hajri
    Department of Health Abu Dhabi,UAE

    Dr. Ashraf Al Zaabi
    President
    Emirates Respiratory Society
    Dubai, UAE

    Dr. Khaled Al Dahmani
    Consultant Endocrinology
    NMC Specialty Hospital
    Al Ain, UAE

    Dr. Buthaina Abdulla Bin Belaila
    Ministry Of Health Dubai, UAE

    Dr. Juwairia Yousif Mohamed Tahir Al Ali
    Vice President
    Cardiologist Rashid Hospital
    Dubai, UAE

    Melanie B. Turner
    MPH, FAHA
    International Science Program Director
    American Heart Association
    USA

    Dr. Nooshin Bazargani
    MD,FRCP(UK) Chair,
    CVD prevention group,
    Emirates Cardiac Society Consultant Cardiologist
    DH-DHA
    Dubai,UAE

    Dr. Ibtihal Fadhil
    Consultant, Non communicable Diseases
    Ministry of Health
    Dubai, UAE

    Dr. Falah Abdul-Hamid Al Khatib
    MEDICLINIC CITY HOSPITAL
    Dubai Healthcare City
    Dubai, UAE

    Dr. Nooshin Bazargani
    MD,FRCP(UK) Chair,
    CVD prevention group,
    Emirates Cardiac Society Consultant Cardiologist
    DH-DHA
    Dubai,UAE

    Dr. Juma Musabah Mohd Alkaabi
    Consultant Endocrinology Tawam Hospital
    Abu Dhabi, UAE

    Dr. Shareena Khamis Al Mazroie
    Deparment Of Health
    Abu Dhabi, UAE

    Dr. Wael Almahmeed
    Consultant Cardiologist
    Heart and Vascular Institute
    Cleaveland Clinic
    Abu Dhabi, UAE

    Dr. Hani Jneid
    Director Interventional Cardiology
    Baylor College of Medicine
    USA

    Assoc Prof. Humaid Alshamsi
    MD, MRCP(UK), FRCPC, FRCP
    President Emirates Oncology Society
    Consultant Medical Oncologist
    Tawam Hospital
    Abu Dhabi, UAE

    Dr. Douglas Bettcher
    Director of WHO’s Prevention of
    Noncommunicable Diseases USA

    Kathryn Taubert
    Vice President International Science &
    Health Strategies
    USA

    International Faculty

    Prof. Mitchell S.V. Elkind
    MD, MS, Mphil, FAAN, FAHA
    President-Elect American Heart Association
    USA

    Prof. Salim S. Virani
    Director, Cardiovascular Disease Fellowship Training Program
    Professor Cardiology/Cardiovascular Research
    Baylor College of Medicine
    Michael E. DeBakey Veterans Affairs Medical Center
    Texas, USA

    Dr. Habibeh Gitiforooz
    FACOG, MBA
    Associate Professor of Surgery at Cleveland Clinic Lerner College of Medicine of Case Western Reserve University
    Director of women health and surgery Cleveland
    USA

    Prof. Majid Rashidi
    Director of Fenn Academy
    Cleveland State University
    USA

    Assoc. Prof. Tochukwu M Okwuosa
    DO, FACC,
    Founder of Chicago Citywide Cardio-Oncology Rounds
    Vice Chair for Cardio-Oncology Council American Heart Association (AHA),
    Assistant Editor for the new JACC: CardioOncology Journal
    Director of Cardio-Oncology Program
    Rush University Medical Center
    Chicago, USA

    Dr. Donna Arnett
    Dean
    College of Public Health
    University of Kentucky
    USA

    Dr. Douglas Bettcher
    Director of WHO’s Prevention of
    Noncommunicable Diseases
    USA

    Regional Faculty

    Prof. Nizal Sarrafzadegan
    Faculty of Medicine, University of British Columbia, Vancouver, Canada.
    Founder and Secretary General, Iranian Heart Foundation,
    Director of Isfahan Cardiovascular Research Institute,
    Isfahan University of Medical Sciences
    Isfahan, Iran

    Dr. Tabandeh
    Iran

    Prof. Saeid Hosseini
    Head of Heart Valve Diseases
    Research Center
    Consultant Cardiac Surgery
    Rajaei Cardiovascular
    Medical & Research Center
    Tehran, Iran

    Prof. Feridoun Noohi,
    MD. FACC, FESC
    President of Iranian Heart Association
    President of Rajaei Cardiovascular Medical & Research Center
    Tehran, Iran

    Scientific Program

    SCIENTIFIC PROGRAM HIGHLIGHTS

    • Current situation on NCDs: Success and challenges and future directions
    • Multi-disciplinary patient management in practice
    • The latest on cardio-oncology
    • Ongoing problems with tobacco use
    • Diabetic medications in cardiology
    • Sleep disorders as risk factors for CVD
    • Pulmonary Hypertension 2019: A roadmap for cardiologists
    • The 2019 ESC/EASD diabetes guidelines: A major paradigm shift in the management of T2DM
    • Taking guidelines into clinical practice
    • Unresolved issues of mental health
    • Late-breaking clinical trials
    • How to reduce NCDs in primary healthcare setting
    • E-Health

    WORKSHOP TOPICS

    • Talking to Cardiologists and Diabetologists
    • Is it the heart or is it the lung?
    • How to reduce NCDs in primary healthcare setting?
    • How to prescribe physical activity in primary healthcare setting?
    • How to solve obesity?
    • How to convince policy makers?
    • Leaders of future; where you should start?
    • Nurses and NCDs

    TARGET AUDIENCE

    • All Physicians
    • Primary Healthcare Practitioners
    • Nursing and Paramedical Staff
    • Epidemiologists and Public Health Professionals
    • Medical Trainees, Residents and Fellows
    • Researchers
    Abstract Submission

    You are invited to submit an abstract for the 2nd Congress in the UAE, taking place 07th & 08th January, 2021 in Dubai, United Arab Emirates.
    Note – The abstracts already submitted for the June 2020 Congress dates, will automatically be considered for the new dates.
    Hence, no need to submit the same abstract again.

    Submission Deadline:
    Tuesday, November 24, 2020
    23:59 Hrs (UAE time)

    Notification on Acceptance/Rejection:
    Wednesday, December 16, 2020
    23:59 Hrs (UAE time)

    Language and content

    All abstracts must be submitted in English using the online submission form on the www.NCDCongressuae.ae website with a limit of 2,245 characters (approx. 300 words)

    General conditions

    • Abstracts must be submitted in English.
    • Please note that only electronic submissions are accepted.
    • Participation is accepted in 2 ways: Abstract Presentation as Posters or Oral Presentation
    • Withdrawal of abstracts can only be accepted if notified in writing. It is possible to withdraw an abstract 14 days after notification on acceptance.
    • If selected, it is the responsibility of the presenter to bear his travel and accommodation expenses.
    • If the Abstract gets approved as a Poster, the specifications of the poster shall be sent to the accepted abstract authors at later stage in a separate email
    • If the abstract get approved as an Oral Abstract, then please note that the Oral presentations are assigned as a Scientific Session during the Congress, and the details will be communicated at later stage in a separate email
    • The same abstract and title submission indicated while submitting, needs to be used during the congress and not another topic can fill your currently accepted slot.

    Presenting Author and Registration

    • The presenting author will get free registration as an active participant to attend the Congress.
    • All the other co-authors must register as an active participant to attend the congress, at the latest 14 days after the notification of acceptance received for the abstract.
    • 2nd NCD Congress Review Committee reserves the right to exclude any abstract from the scientific program that is not followed by a participant registration at the latest 14 days after notification on acceptance.

    Contents of your abstract

    • The abstract word limit is max. 250 words per abstract. 2nd NCD Congress Secretariat reserves the right to edit abstracts that exceed the word limit.
    • The title should be as brief as possible but long enough to clearly indicate the nature of the study. Write the abstract title in CAPITAL LETTERS. No full stop at the end.
    • No identifying features such as names of authors, hospitals, medical schools, clinics or cities may be listed in the title or abstract text, as a “blind” review process will be used. You will be asked to enter the name(s) of author(s) and their institution(s), when you submit your abstract online.

    The abstract must include the following:
    Aim: Clearly state the purpose of the abstract.
    Methods: Describe your selection of observations or experimental subjects clearly.
    Results: Present your results in a logical sequence in text, table and illustrations.
    Conclusions: Emphasize new and important aspects of the study (perhaps as a discussion section) and the conclusions that are drawn from them.
    All abbreviations must be defined in first use.
    Statements such as “results will be discussed” or “data will be presented” cannot be accepted.
    Use of brand names for all references to products or companies, generic names must be used. The brand name can be inserted as a reference at the bottom of the abstract page. Papers containing brand names/company names in the abstract text (i.e. not in a reference at the bottom of the page) may be rejected for this reason only. 2nd NCD Congress Secretariat reserves the right to replace any brand name with a generic name without further notice.
    Images that are uploaded to follow the abstract are not guaranteed inclusion in the Congress Materials.

    Reviewing

    • The scientific committee will review the abstract.
    • Notification of acceptance or rejection of the abstract will be sent to all authors by 16th December, 2020
    • It is the responsibility of all investigators that all studies are performed with respect to national legislation, international legislation and ethical guidelines both with regards to humans and animals. 2nd NCD Congress Committee reserves the right to reject any submitted abstract that is believed to violate these principles
    • Please verify that your email address (submitter and presenting author) is correct as it will be used for contacting you after the review process.
    Registration Fees
    2nd NCD Congress Registration, 07 & 08 January, 2021
    Registration Categories
    Early Bird Rate until 29th Nov 2020
    Regular Rate 30th Nov - 30th Dec 2020
    Onsite Rate 31th Dec 2020 onwards
    Physicians
    AED 1500 – US$ 430
    AED 1700 – US$ 490
    AED 2000 – US$ 575
    Non-Physicians, Nurses & Residents
    AED 600 – US$ 170
    AED 750 – US$ 215
    AED 900 – US$ 255
    Students
    AED 430 - US$ 125
    AED 490 - US$ 140
    AED 575 - US$ 165
    *Above rates are subject to 5% VAT as mandated by UAE Government Law
    Venue and Accommodation

    INTERCONTINENTAL DUBAI – FESTIVAL CITY

    Dubai Festival City
    P.O. Box 45777
    Dubai, United Arab Emirates
    CHECK IN: 3PM (EARLY CHECK IN AVAILABLE)
    CHECK OUT: 12PM (LATE CHECK OUT AVAILABLE)
    E-MAIL HOTEL
    +971-4-7011111

    Sponsors & Exhibitors

    Destination Partner

    Enhance your brand position and increase your exposure driving real value. Ensure your company stands out from the crowd by taking up one or more of these value-added opportunities!

    Sponsorship of the Second NCD Congress provides an excellent opportunity for companies operating within this exciting field to explore the market and interact to build lasting relationships with current and prospective clients at all levels and segments – corporate and government departments.

    • Meeting your target audience face-to-face
    • Direct selling to serious buyers in an active buying mode
    • Building prospect databases
    • Generating high-quality sales leads
    • Building relationships with existing customers
    • Demonstrating products / services
    • Generating media exposure
    • Building brand awareness
    • Launching new products/ services
    • Positioning your company as a market leader
    • Targeting, testing and developing new markets
    • Conducting market research
    • Identifying and recruiting new distributors or partners
    • Networking with industry peers
    • - select your title -
    • Mr.
    • Mis.
    • Dr.
    Field is required!
    Field is required!
    Field is required!
    Field is required!
    Field is required!
    Field is required!
    Field is required!
    Field is required!
    • - select your country -
    • Åland Islands
    • Afghanistan
    • Albania
    • Algeria
    • American Samoa (US)
    • Andorra
    • Angola
    • Antigua and Barbuda
    • Argentina
    • Armenia
    • Australia
    • Austria
    • Azerbaijan
    • Bahamas
    • Bahrain
    • Bangladesh
    • Barbados
    • Belarus
    • Belgium
    • Belize
    • Benin
    • Bermuda (UK)
    • Bhutan
    • Bolivia
    • Bosnia and Herzegovina
    • Botswana
    • Brazil
    • Brunei
    • Bulgaria
    • Burkina Faso
    • Burma (Myanmar)
    • Burundi
    • Cambodia
    • Cameroon
    • Canada
    • Cape Verde
    • Central African Republic
    • Chad
    • Chile
    • China
    • Colombia
    • Comoros
    • Congo, Democratic Republic of the
    • Congo, Republic of the
    • Cook Islands (NZ)
    • Costa Rica
    • Croatia
    • Cuba
    • Cyprus
    • Czech Republic
    • Denmark
    • Djibouti
    • Dominica
    • Dominican Republic
    • East Timor (Timor-Leste)
    • Ecuador
    • Egypt
    • El Salvador
    • Equatorial Guinea
    • Eritrea
    • Estonia
    • Ethiopia
    • Falkland Islands (UK)
    • Faroe Islands (Denmark)
    • Fiji
    • Finland
    • France
    • French Guiana
    • French Polynesia (France)
    • Gabon
    • Gambia
    • Georgia
    • Germany
    • Ghana
    • Gibraltar (UK)
    • Greece
    • Greenland (Denmark)
    • Grenada
    • Guam (US)
    • Guatemala
    • Guernsey (UK)
    • Guinea
    • Guinea-Bissau
    • Guyana
    • Haiti
    • Honduras
    • Hong Kong (China)
    • Hungary
    • Iceland
    • India
    • Indonesia
    • Iran
    • Iraq
    • Ireland
    • Isle of Man (UK)
    • Israel
    • Italy
    • Ivory Coast
    • Jamaica
    • Japan
    • Jersey (UK)
    • Jordan
    • Kazakhstan
    • Kenya
    • Kiribati
    • Korea, North
    • Korea, South
    • Kosovo
    • Kuwait
    • Kyrgyzstan
    • Laos
    • Latvia
    • Lebanon
    • Lesotho
    • Liberia
    • Libya
    • Liechtenstein
    • Lithuania
    • Luxembourg
    • Macau (China)
    • Macedonia
    • Madagascar
    • Malawi
    • Malaysia
    • Maldives
    • Mali
    • Malta
    • Marshall Islands
    • Mauritania
    • Mauritius
    • Mayotte (France)
    • Mexico
    • Micronesia, Federated States of
    • Moldova
    • Monaco
    • Mongolia
    • Montenegro
    • Morocco
    • Mozambique
    • Namibia
    • Nauru
    • Nepal
    • Netherlands
    • New Caledonia (France)
    • New Zealand
    • Nicaragua
    • Niger
    • Nigeria
    • Niue (NZ)
    • Norfolk Island (Australia)
    • Northern Mariana Islands (US)
    • Norway
    • Oman
    • Pakistan
    • Palau
    • Palestinian territories
    • Panama
    • Papua New Guinea
    • Paraguay
    • Peru
    • Philippines
    • Pitcairn Islands (UK)
    • Poland
    • Portugal
    • Qatar
    • Réunion (France)
    • Romania
    • Russian Federation
    • Rwanda
    • São Tomé and Príncipe
    • Saint Helena, Ascension and Tristan da Cunha (UK)
    • Saint Kitts and Nevis
    • Saint Lucia
    • Saint Pierre and Miquelon (France)
    • Saint Vincent and the Grenadines
    • Samoa
    • San Marino
    • Saudi Arabia
    • Senegal
    • Serbia
    • Seychelles
    • Sierra Leone
    • Singapore
    • Slovakia
    • Slovenia
    • Solomon Islands
    • Somalia
    • South Africa
    • South Sudan
    • Spain
    • Sri Lanka
    • Sudan
    • Suriname
    • Svalbard and Jan Mayen (Norway)
    • Swaziland
    • Sweden
    • Switzerland
    • Syria
    • Taiwan
    • Tajikistan
    • Tanzania
    • Thailand
    • Togo
    • Tokelau (NZ)
    • Tonga
    • Trinidad and Tobago
    • Tunisia
    • Turkey
    • Turkmenistan
    • Tuvalu
    • Uganda
    • Ukraine
    • United Arab Emirates
    • United Kingdom
    • United States
    • Uruguay
    • Uzbekistan
    • Vanuatu
    • Vatican City
    • Venezuela
    • Vietnam
    • Wallis and Futuna (France)
    • Western Sahara
    • Yemen
    • Zambia
    • Zimbabwe
    Field is required!
    Field is required!
    Field is required!
    Field is required!

    Exhibiting at the Second NCD Congress presents multiple benefits to your company, including providing a comprehensive platform for targeted promotion and brand exposure where leading members of the Orthopaedic Surgery and related medicine fields interact to encourage networking and educational opportunities, and develop its future. Showcase your products to leading experts and professionals from both corporate and governmental departments as well as allied health specialists practicing Orthopaedic Surgery related medicine.

    Booking is on a first-come-first-served basis. A trade exhibition covering pharmaceutical products, diagnostics and lab tests, lab ware, medical equipment, and instruments, will be organized during the conference at the same venue.

    • - select your title -
    • Mr.
    • Mis.
    • Dr.
    Field is required!
    Field is required!
    Field is required!
    Field is required!
    Field is required!
    Field is required!
    Field is required!
    Field is required!
    • - select your country -
    • Åland Islands
    • Afghanistan
    • Albania
    • Algeria
    • American Samoa (US)
    • Andorra
    • Angola
    • Antigua and Barbuda
    • Argentina
    • Armenia
    • Australia
    • Austria
    • Azerbaijan
    • Bahamas
    • Bahrain
    • Bangladesh
    • Barbados
    • Belarus
    • Belgium
    • Belize
    • Benin
    • Bermuda (UK)
    • Bhutan
    • Bolivia
    • Bosnia and Herzegovina
    • Botswana
    • Brazil
    • Brunei
    • Bulgaria
    • Burkina Faso
    • Burma (Myanmar)
    • Burundi
    • Cambodia
    • Cameroon
    • Canada
    • Cape Verde
    • Central African Republic
    • Chad
    • Chile
    • China
    • Colombia
    • Comoros
    • Congo, Democratic Republic of the
    • Congo, Republic of the
    • Cook Islands (NZ)
    • Costa Rica
    • Croatia
    • Cuba
    • Cyprus
    • Czech Republic
    • Denmark
    • Djibouti
    • Dominica
    • Dominican Republic
    • East Timor (Timor-Leste)
    • Ecuador
    • Egypt
    • El Salvador
    • Equatorial Guinea
    • Eritrea
    • Estonia
    • Ethiopia
    • Falkland Islands (UK)
    • Faroe Islands (Denmark)
    • Fiji
    • Finland
    • France
    • French Guiana
    • French Polynesia (France)
    • Gabon
    • Gambia
    • Georgia
    • Germany
    • Ghana
    • Gibraltar (UK)
    • Greece
    • Greenland (Denmark)
    • Grenada
    • Guam (US)
    • Guatemala
    • Guernsey (UK)
    • Guinea
    • Guinea-Bissau
    • Guyana
    • Haiti
    • Honduras
    • Hong Kong (China)
    • Hungary
    • Iceland
    • India
    • Indonesia
    • Iran
    • Iraq
    • Ireland
    • Isle of Man (UK)
    • Israel
    • Italy
    • Ivory Coast
    • Jamaica
    • Japan
    • Jersey (UK)
    • Jordan
    • Kazakhstan
    • Kenya
    • Kiribati
    • Korea, North
    • Korea, South
    • Kosovo
    • Kuwait
    • Kyrgyzstan
    • Laos
    • Latvia
    • Lebanon
    • Lesotho
    • Liberia
    • Libya
    • Liechtenstein
    • Lithuania
    • Luxembourg
    • Macau (China)
    • Macedonia
    • Madagascar
    • Malawi
    • Malaysia
    • Maldives
    • Mali
    • Malta
    • Marshall Islands
    • Mauritania
    • Mauritius
    • Mayotte (France)
    • Mexico
    • Micronesia, Federated States of
    • Moldova
    • Monaco
    • Mongolia
    • Montenegro
    • Morocco
    • Mozambique
    • Namibia
    • Nauru
    • Nepal
    • Netherlands
    • New Caledonia (France)
    • New Zealand
    • Nicaragua
    • Niger
    • Nigeria
    • Niue (NZ)
    • Norfolk Island (Australia)
    • Northern Mariana Islands (US)
    • Norway
    • Oman
    • Pakistan
    • Palau
    • Palestinian territories
    • Panama
    • Papua New Guinea
    • Paraguay
    • Peru
    • Philippines
    • Pitcairn Islands (UK)
    • Poland
    • Portugal
    • Qatar
    • Réunion (France)
    • Romania
    • Russian Federation
    • Rwanda
    • São Tomé and Príncipe
    • Saint Helena, Ascension and Tristan da Cunha (UK)
    • Saint Kitts and Nevis
    • Saint Lucia
    • Saint Pierre and Miquelon (France)
    • Saint Vincent and the Grenadines
    • Samoa
    • San Marino
    • Saudi Arabia
    • Senegal
    • Serbia
    • Seychelles
    • Sierra Leone
    • Singapore
    • Slovakia
    • Slovenia
    • Solomon Islands
    • Somalia
    • South Africa
    • South Sudan
    • Spain
    • Sri Lanka
    • Sudan
    • Suriname
    • Svalbard and Jan Mayen (Norway)
    • Swaziland
    • Sweden
    • Switzerland
    • Syria
    • Taiwan
    • Tajikistan
    • Tanzania
    • Thailand
    • Togo
    • Tokelau (NZ)
    • Tonga
    • Trinidad and Tobago
    • Tunisia
    • Turkey
    • Turkmenistan
    • Tuvalu
    • Uganda
    • Ukraine
    • United Arab Emirates
    • United Kingdom
    • United States
    • Uruguay
    • Uzbekistan
    • Vanuatu
    • Vatican City
    • Venezuela
    • Vietnam
    • Wallis and Futuna (France)
    • Western Sahara
    • Yemen
    • Zambia
    • Zimbabwe
    Field is required!
    Field is required!
    Field is required!
    Field is required!
    Contact Us
    IPE Logo-01
    InfoPlus Events LLC is a dynamic and creative event management company catering with a “Plus” to associations and corporate clients.
    Lake Central Tower, Business Bay, Dubai – UAE